BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2377207)

  • 21. Immunogenetics of nasopharyngeal carcinoma--position in 1980.
    Chan SH
    Ann Acad Med Singap; 1980 Jul; 9(3):296-9. PubMed ID: 7212610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinico-immunogenetic study on Egyptian multicase tuberculous families.
    Hafez M; el-Fiky A; Bassiouny MR; el-Hafez SA; el-Morsy A; Khaled A; el-Ziny M; al-Tonbary Y; Settein A
    Dis Markers; 1992; 10(3):143-9. PubMed ID: 1294359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasopharyngeal carcinoma and histocompatibility antigens.
    Simons MJ; Chan SH; Wee GB; Shanmugaratnam K; Goh EH; Ho JH; Chau JC; Darmalingam S; Prasad U; Betuel H; Day NE; de-The G
    IARC Sci Publ (1971); 1978; (20):271-82. PubMed ID: 730194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple low-frequency and rare HLA-B allelic variants are associated with reduced risk in 1,105 nasopharyngeal carcinoma patients in Hunan province, southern China.
    Tian W; Zhu F; Cai J; Li L; Jin H; Wang W
    Int J Cancer; 2020 Sep; 147(5):1397-1404. PubMed ID: 32212153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of HLA-linked susceptibility gene(s) in primary congenital glaucoma.
    Hafez M; Moustafa EE; Mokpel TH; Settein S; el-Serogy H
    Dis Markers; 1990; 8(4):191-7. PubMed ID: 2088635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population.
    Tang M; Zeng Y; Poisson A; Marti D; Guan L; Zheng Y; Deng H; Liao J; Guo X; Sun S; Nelson G; de Thé G; Winkler CA; O'Brien SJ; Carrington M; Gao X
    Genes Immun; 2010 Jun; 11(4):334-42. PubMed ID: 20072141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA and nasopharyngeal cancer.
    Simons MJ; Chan SH; Day NE; Wee GB; Shanmugaratnam K
    Prog Clin Biol Res; 1977; 16():145-8. PubMed ID: 905319
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship between immunoglobulin allotypes and susceptibility to nasopharyngeal carcinoma in Malaysia.
    Tarone RE; Levine PH; Yadav M; Pandey JP
    Cancer Res; 1990 Jun; 50(11):3186-8. PubMed ID: 1692255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis.
    Goldsmith DB; West TM; Morton R
    Clin Otolaryngol Allied Sci; 2002 Feb; 27(1):61-7. PubMed ID: 11903375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between HLA-A2-Bw46-DRw8 haplotype and increased levels of complement components (C4 and C4a) in patients with psoriatic arthritis.
    Muto M; Mashimo M; Urabe K; Suzuki T; Sasazuki T
    Arch Dermatol Res; 1991; 283(5):347-9. PubMed ID: 1929558
    [No Abstract]   [Full Text] [Related]  

  • 31. HLA and nasopharyngeal carcinoma in Chinese--a further study.
    Chan SH; Day NE; Kunaratnam N; Chia KB; Simons MJ
    Int J Cancer; 1983 Aug; 32(2):171-6. PubMed ID: 6874140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasopharyngeal carcinoma as a paradigm of cancer genetics.
    Simons MJ
    Chin J Cancer; 2011 Feb; 30(2):79-84. PubMed ID: 21272439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between microsatellites within the human MHC and nasopharyngeal carcinoma.
    Ooi EE; Ren EC; Chan SH
    Int J Cancer; 1997 Apr; 74(2):229-32. PubMed ID: 9133461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haplotypes of human leukocyte antigens among patients with nasopharyngeal cancer in Greece.
    Daniilidis M; Fountzilas G; Fleva A; Daniilidis J; Tourkantonis A
    Oncology; 1997; 54(3):185-92. PubMed ID: 9143397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HLA system and malignant diseases (author's transl)].
    Feingold N
    Bull Cancer; 1978; 65(1):79-82. PubMed ID: 667376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA and ragweed allergy.
    Blumenthal M; Mendell NR; Yunis E; Amos DB; Muscoplat C; Elston RC
    Monogr Allergy; 1977; 11():83-8. PubMed ID: 876131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus.
    Zeng Z; Zhou Y; Zhang W; Li X; Xiong W; Liu H; Fan S; Qian J; Wang L; Li Z; Shen S; Li G
    Genet Med; 2006 Mar; 8(3):156-60. PubMed ID: 16540749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping.
    Lu CC; Chen JC; Tsai ST; Jin YT; Tsai JC; Chan SH; Su IJ
    Int J Cancer; 2005 Jul; 115(5):742-6. PubMed ID: 15729690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of HLA-B alleles in nasopharyngeal carcinoma patients and normal controls in Thailand.
    Pimtanothai N; Charoenwongse P; Mutirangura A; Hurley CK
    Tissue Antigens; 2002 Mar; 59(3):223-5. PubMed ID: 12074714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US Caucasians.
    Burt RD; Vaughan TL; Nisperos B; Swanson M; Berwick M
    Int J Cancer; 1994 Feb; 56(4):465-7. PubMed ID: 8112882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.